- Home
- WEST vs KROS Comparison
WEST vs KROS Comparison
Compare WEST & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WEST | KROS |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 492.8M | 584.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | WEST | KROS |
|---|---|---|
| Price | $4.91 | $15.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $9.00 | ★ $23.00 |
| AVG Volume (30 Days) | 236.3K | ★ 252.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.85 |
| EPS | N/A | ★ 2.68 |
| Revenue | N/A | N/A |
| Revenue This Year | $39.88 | $6,898.87 |
| Revenue Next Year | $14.87 | N/A |
| P/E Ratio | ★ N/A | $5.83 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.59 | $9.12 |
| 52 Week High | $7.92 | $22.55 |
Technical Indicators
Market Signals| Indicator | WEST | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 54.83 | 27.95 |
| Support Level | $4.49 | $15.12 |
| Resistance Level | $5.20 | $16.12 |
| Average True Range (ATR) | 0.20 | 0.59 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 34.34 | 3.02 |
Price Performance
Historical ComparisonAbout WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.